BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatosis
1
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
7/4/2022 12:30:52 PM | Browse: 275 | Download: 446
2
Metabolic aspects of hepatitis C virus
6/10/2022 5:40:20 AM | Browse: 313 | Download: 534
3
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 358 | Download: 523
4
Glycogen hepatopathy in type-1 diabetes mellitus: A case report
2/22/2022 9:25:38 AM | Browse: 266 | Download: 442
5
Nonalcoholic fatty liver disease shows significant sex dimorphism
2/11/2022 5:55:19 AM | Browse: 281 | Download: 775
6
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
1/21/2022 8:16:14 AM | Browse: 381 | Download: 663
7
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
10/20/2021 7:18:39 AM | Browse: 269 | Download: 334
8
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
9/7/2021 8:15:21 AM | Browse: 469 | Download: 509
9
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
8/4/2021 7:56:20 AM | Browse: 312 | Download: 673
10
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
7/12/2021 12:42:13 AM | Browse: 451 | Download: 862
11
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 385 | Download: 902
12
Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
6/18/2021 5:06:16 AM | Browse: 392 | Download: 866
13
Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients
5/8/2021 7:57:00 AM | Browse: 464 | Download: 892
14
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
3/18/2021 10:54:40 AM | Browse: 563 | Download: 748
15
Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
2/5/2021 10:20:18 AM | Browse: 466 | Download: 1009
16
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
11/24/2020 12:41:21 PM | Browse: 528 | Download: 1072
17
Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
11/6/2020 7:36:12 AM | Browse: 549 | Download: 1166
18
Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis
9/4/2020 7:25:49 AM | Browse: 564 | Download: 1305
19
Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
8/7/2019 7:09:17 AM | Browse: 771 | Download: 1057
20
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 726 | Download: 799
21
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 909 | Download: 1462
22
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 1006 | Download: 1158
23
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 981 | Download: 1249
24
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
1/21/2019 5:38:30 AM | Browse: 1027 | Download: 1161
25
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 1132 | Download: 1339
26
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 790 | Download: 1111
27
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
9/25/2018 3:44:36 AM | Browse: 935 | Download: 1229
28
Feasibility of using marginal liver grafts in living donor liver transplantation
6/15/2018 9:13:16 AM | Browse: 1062 | Download: 1064
29
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 1119 | Download: 945
30
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 1195 | Download: 1646
31
circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
1/19/2018 9:46:49 AM | Browse: 1102 | Download: 1156
32
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 956 | Download: 1493
33
Non-alcoholic fatty liver disease: An expanded review
6/6/2017 12:54:56 AM | Browse: 1395 | Download: 1267
34
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
5/20/2017 12:26:24 PM | Browse: 1129 | Download: 1286
35
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
5/16/2017 6:56:36 AM | Browse: 1300 | Download: 1920
36
Non-alcoholic fatty liver disease and cardiovascular risk
5/16/2017 6:56:36 AM | Browse: 1289 | Download: 1189
37
Changes in human hepatic metabolism in steatosis and cirrhosis
4/20/2017 3:58:56 PM | Browse: 1533 | Download: 1994
38
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
1/19/2017 11:16:00 AM | Browse: 1425 | Download: 1664
39
Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
12/27/2016 8:31:00 AM | Browse: 1371 | Download: 1840
40
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 1203 | Download: 1532
41
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
11/6/2016 3:43:00 PM | Browse: 1256 | Download: 1215
42
Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease
9/22/2016 9:52:00 AM | Browse: 1268 | Download: 2149
43
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease
3/29/2016 3:29:00 PM | Browse: 1237 | Download: 2158
44
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver
1/26/2016 6:22:00 PM | Browse: 1357 | Download: 2005
45
Mechanisms of intrahepatic triglyceride accumulation
1/20/2016 5:04:00 PM | Browse: 1314 | Download: 1332
46
Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis
12/4/2015 3:24:00 PM | Browse: 1156 | Download: 1459
47
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
12/2/2015 12:20:00 PM | Browse: 1297 | Download: 1032
48
Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan®)
11/11/2015 1:33:00 PM | Browse: 1408 | Download: 1724
49
Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice
10/30/2015 11:57:00 AM | Browse: 1057 | Download: 2020
50
Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
9/9/2015 2:44:00 PM | Browse: 1329 | Download: 1558
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345